PROVIDER PROFILE · NPI 1407277833

Melissa Alegre-GuzmanNURSE PRACTITIONER

PRACTICEALYSON FLAKER, RDN LLCSee all providers at this practice →

Nurse PractitionerHackensack, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

277

Unique beneficiaries

—

Total services

402

Distinct HCPCS

Medicare payment

$22K

Peer benchmark

Total Medicare services vs. 4,852 Nurse Practitioner providers in NJ — above median (cohort median 291).

PRESCRIBING · PART D · 2024

Total Rx claims

1,853

Beneficiaries

—

Total drug cost

$137K

Distinct drugs

Brand share

16.9%

Top prescribed drugs

Levothyroxine Sodium114 claims

Lisinopril98 claims

Amlodipine Besylate78 claims

Pantoprazole Sodium73 claims

Sertraline Hcl68 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

80.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Melissa Alegre-Guzman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HMH HOSPITALS CORPORATION	38	125

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Ez Clinical Laboratory Inc Clinical Laboratory · East Brunswick, NJ	63	190
Ehab Ibrahim Internal Medicine · Hackensack, NJ	52	105
HMH HOSPITALS CORPORATION	46	185
Suhel Ahmed Internal Medicine · Hackensack, NJ	12	40

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history